E09.3553Billable
Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy, bilateral
Short description: Drug/chem diabetes with stable prolif diabetic rtnop, bi
- Chapter
- 4. Endocrine, nutritional and metabolic diseases
- Category
- E09
- Effective date
- October 1, 2026
Related codes in category E09
E09Drug or chemical induced diabetes mellitusE09.0Drug or chemical induced diabetes mellitus w hyperosmolarityE09.00Drug/chem diab w hyprosm w/o nonket hyprgly-hypros comaYesE09.01Drug/chem diabetes mellitus w hyperosmolarity w comaYesE09.1Drug or chemical induced diabetes mellitus with ketoacidosisE09.10Drug/chem diabetes mellitus w ketoacidosis w/o comaYesE09.11Drug/chem diabetes mellitus w ketoacidosis w comaYesE09.2Drug/chem diabetes mellitus w kidney complicationsE09.21Drug/chem diabetes mellitus w diabetic nephropathyYesE09.22Drug/chem diabetes w diabetic chronic kidney diseaseYesE09.29Drug/chem diabetes w oth diabetic kidney complicationYesE09.3Drug/chem diabetes mellitus w ophthalmic complications
Frequently asked questions
What is ICD-10 code E09.3553?
E09.3553 is an ICD-10-CM diagnosis code for Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy, bilateral.
Is E09.3553 a billable code?
Yes. E09.3553 is billable and specific enough to be used on a claim.
What ICD-10-CM chapter is E09.3553 in?
E09.3553 falls under Chapter 4: Endocrine, nutritional and metabolic diseases.
When did E09.3553 become effective?
E09.3553 has been effective since October 1, 2026, per the CMS/CDC ICD-10-CM annual release.
What other codes are related to E09.3553?
E09.3553 belongs to category E09, which includes 12 other codes — see the related codes list on this page.
ICD-10-CM data maintained by CDC/CMS (public domain). Always verify codes with authoritative sources before making coding or billing decisions.